Colgate-Palmolive Company (CL) Shares Bought by First Eagle Investment Management LLC

First Eagle Investment Management LLC boosted its holdings in Colgate-Palmolive Company (NYSE:CL) by 2.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,891,131 shares of the company’s stock after acquiring an additional 108,850 shares during the quarter. First Eagle Investment Management LLC owned about 0.56% of Colgate-Palmolive worth $362,580,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in CL. Douglass Winthrop Advisors LLC grew its holdings in Colgate-Palmolive by 0.9% in the second quarter. Douglass Winthrop Advisors LLC now owns 483,526 shares of the company’s stock valued at $35,844,000 after purchasing an additional 4,426 shares during the last quarter. First Personal Financial Services grew its holdings in Colgate-Palmolive by 59.1% in the second quarter. First Personal Financial Services now owns 56,044 shares of the company’s stock valued at $4,155,000 after purchasing an additional 20,822 shares during the last quarter. Bridgewater Wealth & Financial Management LLC grew its holdings in Colgate-Palmolive by 1.6% in the second quarter. Bridgewater Wealth & Financial Management LLC now owns 9,224 shares of the company’s stock valued at $684,000 after purchasing an additional 149 shares during the last quarter. Hartland & Co. LLC grew its holdings in Colgate-Palmolive by 5.4% in the second quarter. Hartland & Co. LLC now owns 22,110 shares of the company’s stock valued at $1,639,000 after purchasing an additional 1,142 shares during the last quarter. Finally, Ballentine Partners LLC grew its holdings in Colgate-Palmolive by 55.1% in the second quarter. Ballentine Partners LLC now owns 6,105 shares of the company’s stock valued at $438,000 after purchasing an additional 2,168 shares during the last quarter. Hedge funds and other institutional investors own 73.09% of the company’s stock.

Several research firms have weighed in on CL. SunTrust Banks, Inc. raised Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their target price for the company from $65.00 to $85.00 in a report on Wednesday, October 11th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Sunday, October 8th. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. BidaskClub lowered Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, August 24th. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $76.85.

In other news, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total transaction of $273,867.85. Following the transaction, the insider now owns 53,173 shares in the company, valued at $3,799,210.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Justin Skala sold 74,374 shares of Colgate-Palmolive stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the transaction, the chief operating officer now owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. Insiders have sold 214,136 shares of company stock worth $15,416,385 over the last ninety days. 1.02% of the stock is owned by insiders.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://ledgergazette.com/2017/10/20/colgate-palmolive-company-cl-shares-bought-by-first-eagle-investment-management-llc.html.

Shares of Colgate-Palmolive Company (NYSE CL) opened at 73.14 on Friday. The firm has a market cap of $64.42 billion, a price-to-earnings ratio of 27.18 and a beta of 0.81. The company’s 50 day moving average price is $72.81 and its 200-day moving average price is $73.23. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. Colgate-Palmolive’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.70 earnings per share. Equities analysts expect that Colgate-Palmolive Company will post $2.90 EPS for the current fiscal year.

The business also recently announced a quarte

A number of other large investors have also added to or reduced their stakes in CL. Douglass Winthrop Advisors LLC grew its holdings in Colgate-Palmolive by 0.9% in the second quarter. Douglass Winthrop Advisors LLC now owns 483,526 shares of the company’s stock valued at $35,844,000 after purchasing an additional 4,426 shares during the last quarter. First Personal Financial Services grew its holdings in Colgate-Palmolive by 59.1% in the second quarter. First Personal Financial Services now owns 56,044 shares of the company’s stock valued at $4,155,000 after purchasing an additional 20,822 shares during the last quarter. Bridgewater Wealth & Financial Management LLC grew its holdings in Colgate-Palmolive by 1.6% in the second quarter. Bridgewater Wealth & Financial Management LLC now owns 9,224 shares of the company’s stock valued at $684,000 after purchasing an additional 149 shares during the last quarter. Hartland & Co. LLC grew its holdings in Colgate-Palmolive by 5.4% in the second quarter. Hartland & Co. LLC now owns 22,110 shares of the company’s stock valued at $1,639,000 after purchasing an additional 1,142 shares during the last quarter. Finally, Ballentine Partners LLC grew its holdings in Colgate-Palmolive by 55.1% in the second quarter. Ballentine Partners LLC now owns 6,105 shares of the company’s stock valued at $438,000 after purchasing an additional 2,168 shares during the last quarter. Hedge funds and other institutional investors own 73.09% of the company’s stock.

Several research firms have weighed in on CL. SunTrust Banks, Inc. raised Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their target price for the company from $65.00 to $85.00 in a report on Wednesday, October 11th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Sunday, October 8th. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. BidaskClub lowered Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, August 24th. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $76.85.

In other news, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total transaction of $273,867.85. Following the transaction, the insider now owns 53,173 shares in the company, valued at $3,799,210.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Justin Skala sold 74,374 shares of Colgate-Palmolive stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the transaction, the chief operating officer now owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. Insiders have sold 214,136 shares of company stock worth $15,416,385 over the last ninety days. 1.02% of the stock is owned by insiders.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://ledgergazette.com/2017/10/20/colgate-palmolive-company-cl-shares-bought-by-first-eagle-investment-management-llc.html.

Shares of Colgate-Palmolive Company (NYSE CL) opened at 73.14 on Friday. The firm has a market cap of $64.42 billion, a price-to-earnings ratio of 27.18 and a beta of 0.81. The company’s 50 day moving average price is $72.81 and its 200-day moving average price is $73.23. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. Colgate-Palmolive’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.70 earnings per share. Equities analysts expect that Colgate-Palmolive Company will post $2.90 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply